Virtual screening for SARS-CoV protease based on KZ7088 pharmacophore points

Journal of Chemical Information and Computer Sciences

Volumn 44, Issue 3, 2004, Pages 1111-1122

  Sirois, Suzanne ^a,b   Wei, Dong Qing ^b,c,d   Du, Qishi ^c   Chou, Kuo Chen ^c,e  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^b Institut Technologique de Montreal   (Canada)

^c TIANJIN NORMAL UNIVERSITY   (China)

^d Gina Cody School of Engineering and Computer Science   (Canada)

^e GORDON LIFE SCIENCE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG-DISCOVERY; DRUGGABILITY; PHARMACOPHORE POINTS; VIRTUAL SCREENING;

BIOASSAY; BLOOD; DATA ACQUISITION; DATABASE SYSTEMS; DERIVATIVES; DRUG PRODUCTS; ENZYMES; HYDROPHOBICITY; PATIENT TREATMENT; PROJECT MANAGEMENT; SYNTHESIS (CHEMICAL); VIRUSES;

PULMONARY DISEASES;

3C LIKE PROTEASE, SARS CORONAVIRUS; 3C-LIKE PROTEASE, SARS CORONAVIRUS; CYSTEINE PROTEINASE; PROTEINASE; VIRUS PROTEIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; HYDROGEN BOND; PROTEIN CONFORMATION; X RAY CRYSTALLOGRAPHY;

CRYSTALLOGRAPHY, X-RAY; CYSTEINE ENDOPEPTIDASES; ENDOPEPTIDASES; HYDROGEN BONDING; MODELS, MOLECULAR; PROTEIN CONFORMATION; VIRAL PROTEINS;

EID: 2942750460     PISSN: 00952338     EISSN: None     Source Type: Journal    
DOI: 10.1021/ci034270n     Document Type: Article

References (23)

1. Oba, Y., The use of corticosteroids in SARS. New Engl. J. Med. 2003, 348, 2034.
2. Anthrax, http://www.chem.ox.ac.uk/anthrax/results.htm, 2002.
3. Richards, W. G. Virtual screening using grid computing: the screen-saver project. Nature Rev. Drug Discovery 2002, 1, 551.
4. Ajay, A.; Walters, W. P.; Murcko, M. A. Can we learn to distinguish between "drug-like" and "nondrug-like" molecules? J. Med. Chem. 1998, 41, 3314.
5. Rishton, G. M. Nonleadlikeness and leadlikeness in biochemical screening. Drug Discovery Today 2003, 8, 86.
6. Sadowski, J.; Kubinyi, H. A scoring scheme for discriminating between drugs and nondrugs. J. Med. Chem. 1998, 41, 3325.
7. Lipinski, C. A. Drug-like properties and the causes of poor solubility and poor permeability, J. Pharmacol. Toxicol. Methods 2000, 44, 235.
8. Xu, J.; Stevenson, J. Drug-like index: a new approach to measure drug-like compounds and their diversity. J. Chem. Inf. Comput. Sci. 2000, 40, 1177.
9. Oprea, T. I. Property distribution of drug-related chemical databases. J. Comput.-Aided Mol. Des. 2000, 14, 251.
10. Rishton, G. M. Reactive compounds and in vitro false positives in HTS, Drug Discovery Today 1997, 2, 382.
11. Baurin, N. Etude et développement de techniques QSAR pour la recherche de molécules d'intérêts thérapeutique, Criblage virtuel et Analyse de chmiothèque, Université d'Orléans, 2002.
12. Anand, K.; Ziebuhr, J.; Wadhwani, P.; Mesters, J. R.; Hilgenfeld, R.; Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science 2003, 300, 1763.
13. Chou, K. C.; Wei, D. Q.; Zhong, W. Z. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem. Biophys. Res. Comm. 2003, 308, 148 (Erratum: ibid. 2003, 310, 675).
14. Wildman, S. A.; Crippen, G. M. Prediction of physicochemical parameters by atomic contributions. J. Chem. Inf. Comput. Sci. 1999, 39, 868.
15. Group, C. C. MOE, H3A 2R7, Montreal, Canada. 2002.
16. WDI, World Drug Index; 14 Great Queen Street, London, WC2B 5DF, UK.
17. Chou, J. J.; Matsuo, H.; Duan, H.; Wagner, G. Solution structure of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell 1998, 94, 171.
18. Chou, J. J.; Li, H.; Salvesen, G. S.; Yuan, J.; Wagner, G. Solution structure of BID, an intracellular amplifier of apoptotic signaling. Cell 1999, 96, 615.
19. Chou, J. J.; Li, S.; Klee, C. B.; Bax, A. Solution structure of Ca2+-calmodulin reveals flexible hand-like properties of its domains. Nature Struct. Biol. 2001, 8, 990.
20. Chou, K. C. The convergence-divergence duality in lectin domains of the selectin family and its implications. FEBS Lett. 1995, 363, 123.
21. Chou, K. C.; Watenpaugh, K. D.; Heinrikson, R. L. A Model of the complex between cyclin-dependent kinase 5(Cdk5) and the activation domain of neuronal Cdk5 activator. Biochem. Biophys. Res. Commun. 1999, 259, 420.
22. Chou, K. C.; Tomasselli, A. G.; Heinrikson, R. L. Prediction of the Tertiary Structure of a Caspase-9/Inhibitor Complex. FEBS Lett. 2000, 470, 249.
23. Chou, K. C.; Howe, W. J. Prediction of the tertiary structure of the beta-secretase zymogen. Biochem. Biophys. Res. Commun. 2002, 292, 702.